SCHEMBL31076349

SCHEMBL31076349

CCC(N[S+]([O-])C(C)(C)C)C(F)(F)S(=O)(=O)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.34
PSIP1 O75475 1/20 0.33
CYP2C19 P33261 2/20 0.33
ABCC9 O60706 1/20 0.33
ABCC8 Q09428 1/20 0.33
KCNJ11 Q14654 1/20 0.33
KCNJ8 Q15842 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ALDH1A1 P00352 2/20 0.31
PRSS1 P07477 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179655 0.87 HTR7 (0.33) HSD11B1CYP2C19ABCC9ABCC8KCNJ11
SCHEMBL27179656 0.87 HTR7 (0.33) HSD11B1CYP2C19ABCC9ABCC8KCNJ11
SCHEMBL30085709 0.82 MMP2 (0.36) KMT2AMAPTNPSR1MMP1MMP9
SCHEMBL27191137 0.82 MMP2 (0.36) KMT2AMAPTNPSR1MMP1MMP9
SCHEMBL29832450 0.82 MCHR1 (0.36) HTTMMP1MMP9MMP13
SCHEMBL27191139 0.82 MMP2 (0.36) KMT2AMAPTNPSR1MMP1MMP9
SCHEMBL25184806 0.80 HSD11B1 (0.35) HSD11B1CYP2C19ABCC9ABCC8KCNJ11
SCHEMBL25184807 0.80 HSD11B1 (0.35) HSD11B1CYP2C19ABCC9ABCC8KCNJ11
SCHEMBL30017983 0.80 HSD11B1 (0.35) HSD11B1CYP2C19ABCC9ABCC8KCNJ11
SCHEMBL25184805 0.80 HSD11B1 (0.35) HSD11B1CYP2C19ABCC9ABCC8KCNJ11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294523-A1 HETEROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) 2024-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294523-A1 HETEROCYCLIC LACTAM COMPOUND, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF RIPK1, RIPK4, RIPK3 HSD11B1 638/4885PSIP1 842/4885CYP2C19 1422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.